Co-Authors
This is a "connection" page, showing publications co-authored by Enrico Cerrato and Andrea Rognoni.
Connection Strength
0.502
-
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE). Int J Cardiol. 2021 01 15; 323:288-291.
Score: 0.056
-
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry. Am J Cardiovasc Drugs. 2019 08; 19(4):429.
Score: 0.052
-
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Int J Cardiol. 2019 09 01; 290:64-69.
Score: 0.051
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
Score: 0.051
-
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI. Eur Heart J Acute Cardiovasc Care. 2019 Sep; 8(6):536-542.
Score: 0.049
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry. Int J Cardiol. 2018 Dec 15; 273:29-33.
Score: 0.049
-
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome. Rev Esp Cardiol (Engl Ed). 2019 Mar; 72(3):215-223.
Score: 0.049
-
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Rev Esp Cardiol (Engl Ed). 2019 Apr; 72(4):298-304.
Score: 0.048
-
Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol. 2018 Nov 01; 270:107-112.
Score: 0.048
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018 07; 167:142-148.
Score: 0.048